Patients who specifically want brand-name FDA-approved GLP-1 medications (oral Wegovy pill, injectable Wegovy, Zepbound, or Ozempic) through a telehealth platform Patients who specifically want a multi-condition membership platform (Hims covers hair loss, ED, mental health, etc.) rather than a focused GLP-1 program Patients with commercial insurance they want to run through pharmacy for brand-name GLP-1 coverage Patients who value Ros broader multi-condition telehealth catalog (sexual health, dermatology, fertility, etc.) under one platform Patients comfortable with a membership-plus-medication pricing model, where the total monthly cost is higher but medication variety is broader How to switch from Ro to Cora Health Patients who want to move their GLP-1 treatment from Ro to Cora Health can generally do so without clinical interruption, though the specific steps depend on medication, dose, and state
Brain behavior immunity-health (2021) 17:100335
Homocysteine and ischemic heart disease: Results of a prospective study with implications regarding prevention
As a scientist, its exciting to conduct research at this scaleusing millions of real-world data points to uncover measurable patterns and actionable insights
Most people notice visible changes within 412 weeks
If the patent claims semaglutide (the base), and the compounder uses semaglutide sodium, they argue they do not literally infringe